Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors
Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions…
Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions…
Renewable power executives say difficulty getting permits, rising costs due to tariffs and the end of key tax credits are…
Lawyers to the rich share tips on how to pass down homes without sibling drama and a massive tax bill.…
The Trump administration has been criticized for reneging on promises to release files about sex offenders Jeffrey Epstein and Ghislaine…
The term "recession" has popped up again as a selling point this summer, perhaps providing a look at how businesses…
Commerce Secretary Howard Lutnick said that the U.S. government has taken a 10% stake in chipmaker Intel. ...
Consumer spending has largely stayed strong so far and the pinch from higher duties hasn't been as severe as some…
Nvidia's Jensen Huang made a visit to Taiwan on Friday, where he showered praise on TSMC, calling it one of…
"There is this ongoing deficit in the in the market, big depletion of availability of cocoa beans and availability of…